Successful eradication of inhibitor in a patient with severe haemophilia B and anaphylaxis to factor IX concentrates: Is there a role for Rituximab® and desensitization therapy?

S. Gamerman*, A. M. Singh, M. Makhija, A. Sharathkumar

*Corresponding author for this work

Research output: Contribution to journalLetter

6 Scopus citations
Original languageEnglish (US)
JournalHaemophilia
Volume19
Issue number6
DOIs
StatePublished - Nov 1 2013

ASJC Scopus subject areas

  • Hematology
  • Genetics(clinical)

Cite this